Infectious Diseases Society of America (IDSA)

The Infectious Diseases Society of America (IDSA) is a global professional medical society representing over 13,000 clinicians, research scientists, and public health practitioners specializing in infectious diseases. Operating at the intersection of clinical medicine, microbiology, and health policy, IDSA coordinates clinical practice guideline synthesis, convenes scientific conferences such as IDWeek, and publishes peer-reviewed research in infectious disease epidemiology. For investigators working in epidemiological research, IDSA provides standardized clinical case definitions, evidence-based management frameworks, and translational publication venues.

What it is

Founded in 1963, the Infectious Diseases Society of America functions as the primary professional body for infectious disease physicians and researchers in the United States and internationally. The organization focuses on human infectious diseases across bacterial, viral, fungal, and parasitic etiologies. IDSA is distinct from broad medical associations in its targeted focus on microbial pathogen management, antimicrobial resistance (AMR), epidemic preparedness, and specialized healthcare-associated infection control.

In research practice, IDSA serves three central functions. First, it standardizes disease definitions and therapeutic recommendations through formal clinical practice guidelines. Second, it operates scholarly communication channels through its academic journal portfolio. Third, alongside partner groups such as the HIV Medicine Association (HIVMA), IDSA advocates for research funding authorizations, antimicrobial pipeline incentives, and public health surveillance infrastructure. Researchers navigating the boundary between clinical practice and population-level disease dynamics often compare institutional approaches through epidemiology and public health frameworks.

Who runs it and what it covers

IDSA is governed by an elected Board of Directors composed of academic medical faculty, practicing clinicians, and public health researchers. Operational guideline development is directed by the Standards and Practice Guidelines Subcommittee (SPGS), which reports to IDSA’s Practice and Quality Committee (PCQ). Society administrative operations and committee programs are headquartered in Arlington, Virginia.

The scope of IDSA covers four core operational areas:

Clinical Practice Guidelines: Rigorous, evidence-based guidance documents covering conditions such as antimicrobial stewardship, healthcare-associated infections, fungal diagnostics, outpatient parenteral antimicrobial therapy (OPAT), and multidrug-resistant pathogens.
Peer-Reviewed Journals: In partnership with Oxford University Press, IDSA oversees three major publications:
- Clinical Infectious Diseases (CID): Publishes original clinical studies, systematic reviews, practice guidelines, and state-of-the-art clinical decision-making reviews.
- The Journal of Infectious Diseases (JID): Focuses on bench-to-bedside translational investigations, microbial pathogenesis, immunology, and laboratory-based virology and bacteriology.
- Open Forum Infectious Diseases (OFID): A fully open-access clinical and translational journal dedicated to broad international dissemination of infectious disease research.
Scientific Assembly (IDWeek): A joint annual scientific conference organized with the Society for Healthcare Epidemiology of America (SHEA), the HIV Medicine Association (HIVMA), the Pediatric Infectious Diseases Society (PIDS), and the Society of Infectious Diseases Pharmacists (SIDP).
The IDSA Foundation: The philanthropic arm supporting research grants, early-career investigator fellowships, and workforce diversification initiatives across infectious disease disciplines.

How to search or use it

Researchers and clinical investigators use IDSA resources primarily through the society’s digital repositories, journal platforms, and guidelines interfaces. The following workflow outlines access to IDSA’s scientific output:

Access the Practice Guidelines Repository: Navigate to the practice guidelines portal via the primary navigation menu on idsociety.org. Users can browse the Alphabetical List of Guidelines or search by pathogen, organ system, or clinical setting.
Review Guideline PICO Frameworks: Access specific guideline documents to inspect clinical questions structured according to the PICO (Population, Intervention, Comparison, Outcome) format, which underpins the systematic review protocol.
Assess GRADE Recommendations: Review the summary-of-findings tables within each guideline. IDSA uses the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) framework to rate the quality of evidence (high, moderate, low, very low) and strength of recommendation (strong vs. conditional).
Consult Mobile Clinical Decision Tools: Practitioners and field epidemiologists can install the official IDSA Practice Guidelines App (available on iOS and Android) for offline reference to clinical algorithms and recommendation summaries.
Access Journal Content and Archives: Query the Oxford University Press platform for CID, JID, and OFID archives. Authors submitting manuscripts must review journal-specific instructions for statistical reporting, clinical trial registration, and open-access licensing fees, which align with standard article processing charges and funder compliance mandates.
Inspect Systematic Review Methodology Tools: Investigators preparing evidence syntheses can consult the IDSA Handbook for Clinical Practice Guidelines Development for screening criteria, risk-of-bias evaluation matrices, and alignment with PRISMA systematic review standards.

Strengths and limits

Understanding IDSA’s institutional strengths and boundary constraints enables researchers to situate its guidance appropriately within the scientific literature.

Strengths

Methodological Rigor: IDSA guidelines adhere to the Institute of Medicine (IOM) standards for developing trustworthy clinical guidelines, incorporating formal conflict-of-interest disclosures and mandatory panel training delivered in partnership with McMaster University.
High Editorial Standards: Journals such as CID and JID maintain rigorous peer-review standards, serving as benchmark outlets for clinical trial results, vaccine efficacy trials, and pathogen surveillance reports.
Multidisciplinary Consensus: Panels feature clinical infectious disease experts, clinical microbiologists, pharmacologists, and methodologists, ensuring guidance reflects cross-specialty clinical realities.

Limits

Jurisdictional Focus: While IDSA guidelines are cited internationally, treatment choices, drug approvals, and diagnostic availability primarily reflect United States regulatory approvals by the FDA.
Update Intervals: Systematic reviews require substantial panel time; comprehensive guideline updates can take 3 to 5 years, necessitating interim guidance documents for emerging pathogens or novel antimicrobial agents.
Subscription Barriers: While practice guidelines are open access, primary research articles in CID and JID may require institutional subscriptions or hybrid publishing fees prior to public archiving.

Alternatives

Researchers and public health specialists consult several alternative and complementary international bodies depending on geographic location, clinical context, and epidemiological focus.

Organization / Platform	Primary Geographic Scope	Key Focus Areas	Guideline Framework	Flagship Publications
IDSA	United States / International	Clinical infectious diseases, therapeutics, antimicrobial stewardship	GRADE methodology, IOM standards	CID, JID, OFID
ESCMID (European Society of Clinical Microbiology and Infectious Diseases)	Europe / International	Clinical microbiology, diagnostic bacteriology, European infectious diseases	GRADE methodology, European consensus	Clinical Microbiology and Infection (CMI)
SHEA (Society for Healthcare Epidemiology of America)	United States / International	Healthcare epidemiology, infection prevention, antibiotic stewardship	Systematic review, expert consensus	Infection Control & Hospital Epidemiology (ICHE)
WHO (World Health Organization)	Global	Global health policy, neglected tropical diseases, international outbreaks	WHO Guideline Development Group (GRADE)	WHO Technical Reports, Weekly Epidemiological Record

FAQ

What does IDSA stand for?

IDSA stands for the Infectious Diseases Society of America, a professional medical and scientific society founded in 1963.

How does IDSA develop clinical practice guidelines?

IDSA develops guidelines through the Standards and Practice Guidelines Subcommittee (SPGS) using the GRADE framework. Panels formulate foreground PICO questions, conduct systematic reviews, evaluate evidence across five quality domains, and assign recommendation strength according to methodological standards established by the Institute of Medicine.

What journals are officially published by IDSA?

IDSA publishes three peer-reviewed journals in partnership with Oxford University Press: Clinical Infectious Diseases (CID), The Journal of Infectious Diseases (JID), and Open Forum Infectious Diseases (OFID).

Can researchers access IDSA clinical practice guidelines for free?

Yes. All official IDSA clinical practice guidelines, updates, and guidance statements are freely accessible to clinicians, researchers, and the public on the society’s official website and mobile application.

Sources

Infectious Diseases Society of America (IDSA), “About IDSA,” https://www.idsociety.org/about-idsa/about-idsa/ (accessed 2026-11-07).
IDSA, “Clinical Practice Guidelines Development: Training and Resources,” https://www.idsociety.org/clinical-practice-guidelines-development-training-and-resources/ (accessed 2026-11-07).
IDSA, “Journals & Publications,” https://www.idsociety.org/journals/journals–publications/ (accessed 2026-11-07).
IDSA, “Practice Guidelines,” https://www.idsociety.org/practice-guideline/practice-guidelines/ (accessed 2026-11-07).